Circulating miR-21 as a Potential Biomarker in Human Digestive System Carcinoma: A Systematic Review and Diagnostic Meta-Analysis.

CONCLUSION: This meta-analysis demonstrated that circulating miR-21 levels can be used to monitor the digestive system carcinomas. Therefore, miR-21 can be a useful biomarker of progression and fair diagnosis in GICs patients. PMID: 33434077 [PubMed - as supplied by publisher]
Source: Biomarkers - Category: Research Tags: Biomarkers Source Type: research